Perguntas frequentes
Glossário

Fechar

Perguntas frequentes

Why are some conditions more suitable for gene and cell therapies than others?

There is an approved treatment available for my condition - why can't I receive it?

How to look for approved medicines?

How are medicines developed and approved?

Ver todas as FAQs

Fechar

Glossário

Adeno-associated virus (AAV)

Adult stem cells

Chimeric Antigen Receptor (CAR)

Ver o glossário completo

Key MHRA Resources

Guidance from the Medicines and Healthcare products Regulatory Agency (MHRA) on Advanced Therapy Medicinal Products (ATMPs):

MHRA Innovative Licensing and Access Pathway

MHRA's ILAP provides enhanced regulatory and expert support for the development of innovative medicines.

Back to: Key Pathway Resources

Achou o conteúdo desta página útil? Se não, pode deixar-nos uma mensagem para que possamos melhorar Envie-nos as suas ideias